OncoSec Medical Incorporated (ONCS) Stock Analysis
DELISTED 2023
What happened to OncoSec Medical Incorporated (ONCS) stock?
OncoSec Medical Incorporated (ONCS) no longer trades on public markets. It was delisted in June 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- June 2023
- Last recorded price (historical):
- $0.2772 (last quote on record before the June 2023 delisting; historical, not a current quote)
Market cap $1.65M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
OncoSec Medical Incorporated (ONCS). OncoSec Medical Incorporated is a late-stage immuno-oncology company focused on developing intra-tumoral DNA-based therapeutics. Their lead product, ImmunoPulse IL-12, aims to stimulate anti-tumor immune responses for cancer treatment.
Last analyzed: Mar 18, 2026OncoSec Medical Incorporated (ONCS) Healthcare & Pipeline Overview
More about this archive record
Can I still buy ONCS shares?
No. ONCS stopped trading on public markets in June 2023, so the shares are not available through a broker. Anything you see quoted for ONCS elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ONCS stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to OncoSec Medical Incorporated. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.